| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6107abcc76ad54b3821249d6315e0ab |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate |
2015-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc5d1ef80c60b4b41b0addc547675dd2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0641827202fae50cbffc65a8ce81f97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21223c4483b81846a39f67f6f1fb4a85 |
| publicationDate |
2017-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2017036255-A |
| titleOfInvention |
Ophthalmic composition |
| abstract |
An ophthalmic composition having characteristics superior to those of conventional ophthalmic compositions is provided. (A) At least one selected from the group consisting of 0.07 w / v% or more of pranoprofen and a salt thereof, and (b) 0.02 w / v% or more of chlorpheniramine and a salt thereof. An ophthalmic composition containing at least one selected from the group consisting of: and / or at least one selected from the group consisting of cromoglycic acid and salts thereof. [Selection] Figure 1 |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021199814-A1 |
| priorityDate |
2015-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |